EziSurg Medical Co., Ltd. was established in November 2011 in Shanghai, specializes in the R&D and industrialization of premium Minimally Invasive Surgery solutions worldwide. With a highly competitive product portfolio including surgical stapling series, surgical energy platform and surgical endoscopy platform, EziSurg is committed to improving surgical outcomes in general, bariatric, thoracic, colorectal, urinary and respiratory procedures, supplying medical professionals and treating patients home and abroad.
By the end of 2022, EziSurg’s products have been used in more than 1,000 hospitals across China, of which Grade 3A hospitals account for more than 40%, and have become the industry leader among domestic brands in the field of minimally invasive surgery solutions in China. In the overseas market, Ezisurg has established global subsidiaries in the United States and the Netherlands, get 155 global certifications including 7 FDA approvals and 14 CE marks, and get entry approval of more than 70 countries and regions in the world.
Countries & regions
We address surgical challenges.
We are committed to exploring better MIS solutions and improve surgical outcomes in general, bariatric, thoracic, colorectal, urinary and respiratory procedures.
We innovate for surgeons and patients.
Technical innovation has ensured EziSurg's leading position in promoting new MIS techniques, creating clinical values and ensuring the very highest quality.
easyEndo™ Powered stapler launched with EU MDR
New HQ park in Shanghai
Endoscopy product launched in China
Hong Kong sub established
3rd-Gen easyEndo™ Lite stapler launched with CE and FDA
Secured C-round funding From Hillhouse Capital
2nd-Gen easyEndo™ Universal stapler launched with CE and FDA: ranking 1st among Chinese brands in home market
easyLC™ Linear Cutter Stapler launched with CE
easyUS™ Ultrasonic Surgical System with CE
Secured B-round funding
easyCS™ Circular Stapler launched with CE
1st-Gen easyEndo™ Unversal Linear Cutting Stapler launched with CE and FDA
Secured A-round funding from IDG Capital
Headquartered in Shanghai, China
To provide premium and affordable minimally invasive surgery devices worldwide
To become a leader in the minimally lnvasive surgery industry in china and a competitive player worldwide
Be pragmatic & efficient
Be a lifelong learner
Innovate to stay ahead
Contribute to social welfare
+86 021 5045 6176
399 Miaoqiao Road, Pudong District, Shanghai, China